Page 244 - Hematology_ Basic Principles and Practice ( PDFDrive )

196 Part II Cellular Basis of Hematology

Numerous signals are capable of modulating cell death. After a death 12. Youle RJ, Strasser A: The BCL-2 protein family: opposing activities that
stimulus, the signal is propagated and amplified through the activation mediate cell death. Nat Rev Mol Cell Biol 9:47–59, 2008.
of caspases, culminating in the ordered disassembly of the cell. The 13. Czabotar PE, Lessene G, Strasser A, et al: Control of apoptosis by the
process may transpire through an intrinsic, mitochondria-dependent BCL-2 protein family: implications for physiology and therapy. Nat Rev
pathway, or an extrinsic pathway depending on the death signal and Mol Cell Biol 15:49–63, 2014.
cell type involved. The BCL-2 family of proteins is situated upstream 14. Urra H, Dufey E, Lisbona F, et al: When ER stress reaches a dead end.
of irreversible cell damage in the apoptotic pathway, providing a Biochim Biophys Acta 1833:3507–3517, 2013.
pivotal checkpoint in the fate of a cell after a death stimulus. The 15. Bonneau B, Prudent J, Popgeorgiev N, et al: Non-apoptotic roles of Bcl-2
proapoptotic molecules BAX and BAK undergo allosteric confor- family: the calcium connection. Biochim Biophys Acta 1833:1755–1765,
mational activation to permeabilize mitochondria upon receipt of a 2013.
death stimulus. BH3-only members connect distinct upstream signal 16. Danial NN, Gimenez-Cassina A, Tondera D: Homeostatic functions
transduction pathways with the common, core apoptotic pathway. of BCL-2 proteins beyond apoptosis. Adv Exp Med Biol 687:1–32,
The distribution and responsiveness of the BH3-only members sug- 2010.
gests that they function as sentinels for recognizing cellular damage. 17. Gimenez-Cassina A, Danial NN: Regulation of mitochondrial nutrient
This model would explain how seemingly diverse cellular injuries and energy metabolism by BCL-2 family proteins. Trends Endocrinol
converge on a final common pathway of cell death. Metab 26:165–175, 2015.
18. Hardwick JM, Chen YB, Jonas EA: Multipolar functions of BCL-2
proteins link energetics to apoptosis. Trends Cell Biol 22:318–328,
REFERENCES 2012.
19. Oberst A, Green DR: It cuts both ways: reconciling the dual roles of
1. Pop C, Salvesen GS: Human caspases: activation, specificity, and regula- caspase 8 in cell death and survival. Nat Rev Mol Cell Biol 12:757–763,
tion. J Biol Chem 284:21777–21781, 2009. 2011.
2. Poreba M, Strozyk A, Salvesen GS, et al: Caspase substrates and inhibi- 20. Yuan J, Kroemer G: Alternative cell death mechanisms in development
tors. Cold Spring Harb Perspect Biol 5:a008680, 2013. and beyond. Genes Dev 24:2592–2602, 2010.
3. Dickens LS, Powley IR, Hughes MA, et al: The ‘complexities’ of life and 21. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al: The biology of cancer:
death: death receptor signalling platforms. Exp Cell Res 318:1269–1277, metabolic reprogramming fuels cell growth and proliferation. Cell Metab
2012. 7:11–20, 2008.
4. Mace PD, Riedl SJ: Molecular cell death platforms and assemblies. Curr 22. Galluzzi L, Pietrocola F, Levine B, et al: Metabolic control of autophagy.
Opin Cell Biol 22:828–836, 2010. Cell 159:1263–1276, 2014.
5. Lamkanfi M, Dixit VM: Mechanisms and functions of inflammasomes. 23. White E: The role for autophagy in cancer. J Clin Invest 125:42–46,
Cell 157:1013–1022, 2014. 2015.
6. Park S, Juliana C, Hong S, et al: The mitochondrial antiviral protein 24. Walter P, Ron D: The unfolded protein response: from stress pathway to
MAVS associates with NLRP3 and regulates its inflammasome activity. homeostatic regulation. Science 334:1081–1086, 2011.
J Immunol 191:4358–4366, 2013. 25. Anderson MA, Huang D, Roberts A: Targeting BCL2 for the treatment
7. Yi CH, Yuan J: The Jekyll and Hyde functions of caspases. Dev Cell of lymphoid malignancies. Semin Hematol 51:219–227, 2014.
16:21–34, 2009. 26. Manion MK, Fry J, Schwartz PS, et al: Small-molecule inhibitors of
8. Gyrd-Hansen M, Meier P: IAPs: from caspase inhibitors to modulators Bcl-2. Curr Opin Investig Drugs 7:1077–1084, 2006.
of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10:561–574, 27. Linton SD, Aja T, Armstrong RA, et al: First-in-class pan caspase inhibitor
2010. developed for the treatment of liver disease. J Med Chem 48:6779–6782,
9. Chi X, Kale J, Leber B, et al: Regulating cell death at, on, and in 2005.
membranes. Biochim Biophys Acta 1843:2100–2113, 2014. 28. Chonghaile TN, Roderick JE, Glenfield C, et al: Maturation stage of
10. Danial NN, Korsmeyer SJ: Cell death: critical control points. Cell T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL
116:205–219, 2004. dependence and sensitivity to ABT-199. Cancer Discov 4:1074–1087,
11. Moldoveanu T, Follis AV, Kriwacki RW, et al: Many players in BCL-2 2014.
family affairs. Trends Biochem Sci 39:101–111, 2014.